Henry Schein (NASDAQ:HSIC) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share guidance of $3.38-3.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.42. Henry Schein also updated its FY 2019 guidance to $3.38-3.50 EPS.
Several analysts have issued reports on HSIC shares. Zacks Investment Research upgraded shares of Henry Schein from a hold rating to a buy rating and set a $78.00 target price on the stock in a research note on Monday, May 13th. BidaskClub cut shares of Henry Schein from a hold rating to a sell rating in a research note on Tuesday, May 7th. Wolfe Research initiated coverage on shares of Henry Schein in a research note on Thursday. They issued an underperform rating on the stock. Guggenheim initiated coverage on shares of Henry Schein in a research report on Wednesday, April 17th. They set a buy rating and a $72.00 price objective on the stock. Finally, Robert W. Baird restated a neutral rating on shares of Henry Schein in a research report on Monday, March 25th. Seven research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of $74.27.
NASDAQ HSIC traded down $0.67 during trading hours on Friday, reaching $64.46. 1,008,407 shares of the company’s stock traded hands, compared to its average volume of 1,808,309. Henry Schein has a 52-week low of $56.58 and a 52-week high of $91.35. The stock has a market cap of $9.75 billion, a P/E ratio of 15.61, a price-to-earnings-growth ratio of 2.29 and a beta of 0.89. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.65 and a quick ratio of 0.93.
In other news, Director Philip A. Laskawy sold 1,084 shares of the business’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $59.86, for a total transaction of $64,888.24. Following the completion of the transaction, the director now directly owns 32,899 shares of the company’s stock, valued at $1,969,334.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.06% of the stock is owned by insiders.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.